The TPMT*2 allele has been assigned as a no function allele by CPIC. Patients carrying the *2 allele in combination with a normal or a no function allele may have decreased likelihood of experiencing toxicity when treated with azathioprine as compared to patients with two normal function alleles. However, conflicting evidence has been reported. Other genetic and clinical factors may also influence azathioprine toxicity.